{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:24:34Z","timestamp":1772814274647,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s42000-019-00161-1","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T23:03:34Z","timestamp":1576019014000},"page":"197-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Diagnosis, treatment, and survival analysis of adrenocortical carcinomas: a multicentric study"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1359-814X","authenticated-orcid":false,"given":"Pedro","family":"Souteiro","sequence":"first","affiliation":[]},{"given":"Sara","family":"Donato","sequence":"additional","affiliation":[]},{"given":"Cl\u00e1udia","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Catarina A.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Sim\u00f5es-Pereira","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Sandra","family":"Belo","sequence":"additional","affiliation":[]},{"given":"Ana Paula","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"Valeriano","family":"Leite","sequence":"additional","affiliation":[]},{"given":"Davide","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Torres","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"issue":"1","key":"161_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/01.ju.0000030148.59051.35","volume":"169","author":"L Ng","year":"2003","unstructured":"Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169(1):5\u201311. https:\/\/doi.org\/10.1097\/01.ju.0000030148.59051.35","journal-title":"J Urol"},{"issue":"11","key":"161_CR2","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.ejca.2013.02.034","volume":"49","author":"TM Kerkhofs","year":"2013","unstructured":"Kerkhofs TM, Verhoeven RH, Van der Zwan JM, Dieleman J, Kerstens MN, Links TP, Van de Poll-Franse LV, Haak HR (2013) Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. European journal of cancer (Oxford, England : 1990) 49(11):2579\u20132586. https:\/\/doi.org\/10.1016\/j.ejca.2013.02.034","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"issue":"6","key":"161_CR3","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1210\/jc.2005-2639","volume":"91","author":"B Allolio","year":"2006","unstructured":"Allolio B, Fassnacht M (2006) Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91(6):2027\u20132037. https:\/\/doi.org\/10.1210\/jc.2005-2639","journal-title":"J Clin Endocrinol Metab"},{"key":"161_CR4","doi-asserted-by":"publisher","unstructured":"Fassnacht M, Dekkers O, Else T, Baudin E, Berruti A, de Krijger RR, Haak HR, Mihai R, Assie G, Terzolo M (2018) European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje-18-0608","DOI":"10.1530\/eje-18-0608"},{"issue":"4","key":"161_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s42000-018-0072-y","volume":"17","author":"CDC Kamilaris","year":"2018","unstructured":"Kamilaris CDC, Stratakis CA (2018) An update on adrenal endocrinology: significant discoveries in the last 10 years and where the field is heading in the next decade. Hormones (Athens) 17(4):479\u2013490. https:\/\/doi.org\/10.1007\/s42000-018-0072-y","journal-title":"Hormones (Athens)"},{"issue":"5","key":"161_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/1097-0142(20010901)92:5<1113::aid-cncr1428>3.0.co;2-i","volume":"92","author":"R Vassilopoulou-Sellin","year":"2001","unstructured":"Vassilopoulou-Sellin R, Schultz PN (2001) Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 92(5):1113\u20131121. https:\/\/doi.org\/10.1002\/1097-0142(20010901)92:5<1113::aid-cncr1428>3.0.co;2-i","journal-title":"Cancer"},{"issue":"1","key":"161_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12020-019-01918-9","volume":"65","author":"I Kostiainen","year":"2019","unstructured":"Kostiainen I, Hakaste L, Kejo P, Parviainen H, Laine T, Loyttyniemi E, Pennanen M, Arola J, Haglund C, Heiskanen I, Schalin-Jantti C (2019) Adrenocortical carcinoma: presentation and outcome of a contemporary patient series. Endocrine 65(1):166\u2013174. https:\/\/doi.org\/10.1007\/s12020-019-01918-9","journal-title":"Endocrine"},{"issue":"3","key":"161_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","volume":"8","author":"LM Weiss","year":"1984","unstructured":"Weiss LM (1984) Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8(3):163\u2013169. https:\/\/doi.org\/10.1097\/00000478-198403000-00001","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"161_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/cncr.24030","volume":"115","author":"M Fassnacht","year":"2009","unstructured":"Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller H-H, Hahner S, Allolio B, Group, f.t.G.A.C.R., Tumors, t.E.N.f.t.S.o.A (2009) Limited prognostic value of the 2004 international union against cancer staging classification for adrenocortical carcinoma. Cancer 115(2):243\u2013250. https:\/\/doi.org\/10.1002\/cncr.24030","journal-title":"Cancer"},{"issue":"2","key":"161_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD (2014) Adrenocortical carcinoma. Endocr Rev 35(2):282\u2013326. https:\/\/doi.org\/10.1210\/er.2013-1029","journal-title":"Endocr Rev"},{"issue":"9","key":"161_CR11","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1002\/1097-0142(19810501)47:9<2153::aid-cncr2820470908>3.0.co;2-6","volume":"47","author":"MS Didolkar","year":"1981","unstructured":"Didolkar MS, Bescher RA, Elias EG, Moore RH (1981) Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer 47(9):2153\u20132161. https:\/\/doi.org\/10.1002\/1097-0142(19810501)47:9<2153::aid-cncr2820470908>3.0.co;2-6","journal-title":"Cancer"},{"issue":"11","key":"161_CR12","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::aid-cncr2820721105>3.0.co;2-n","volume":"72","author":"MD Wooten","year":"1993","unstructured":"Wooten MD, King DK (1993) Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72(11):3145\u20133155. https:\/\/doi.org\/10.1002\/1097-0142(19931201)72:11<3145::aid-cncr2820721105>3.0.co;2-n","journal-title":"Cancer"},{"issue":"6","key":"161_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.surg.2005.09.012","volume":"138","author":"RJ Gonzalez","year":"2005","unstructured":"Gonzalez RJ, Shapiro S, Sarlis N, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE (2005) Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery 138(6):1078\u20131085; discussion 1085-1076. https:\/\/doi.org\/10.1016\/j.surg.2005.09.012","journal-title":"Surgery"},{"issue":"6","key":"161_CR14","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1530\/EJE-13-0519","volume":"169","author":"M Ayala-Ramirez","year":"2013","unstructured":"Ayala-Ramirez M, Jasim S, Feng L, Ejaz S, Deniz F, Busaidy N, Waguespack SG, Naing A, Sircar K, Wood CG, Pagliaro L, Jimenez C, Vassilopoulou-Sellin R, Habra MA (2013) Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol 169(6):891\u2013899. https:\/\/doi.org\/10.1530\/EJE-13-0519","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"161_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","volume":"13","author":"LM Weiss","year":"1989","unstructured":"Weiss LM, Medeiros LJ, Vickery AL Jr (1989) Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13(3):202\u2013206","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"161_CR16","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","volume":"26","author":"R Libe","year":"2015","unstructured":"Libe R, Borget I, Ronchi CL, Zaggia B, Kroiss M, Kerkhofs T, Bertherat J, Volante M, Quinkler M, Chabre O, Bala M, Tabarin A, Beuschlein F, Vezzosi D, Deutschbein T, Borson-Chazot F, Hermsen I, Stell A, Fottner C, Leboulleux S, Hahner S, Mannelli M, Berruti A, Haak H, Terzolo M, Fassnacht M, Baudin E (2015) Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European network for the study of adrenal tumor (ENSAT) study. Annals of oncology : official journal of the European Society for Medical Oncology 26(10):2119\u20132125. https:\/\/doi.org\/10.1093\/annonc\/mdv329","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"issue":"suppl7","key":"161_CR17","doi-asserted-by":"publisher","first-page":"vii131","DOI":"10.1093\/annonc\/mds231","volume":"23","author":"A Berruti","year":"2012","unstructured":"Berruti A, Baudin E, Gelderblom H, Haak HR, Porpiglia F, Fassnacht M, Pentheroudakis G, on behalf of the, E.G.W.G (2012) Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(suppl7):vii131\u2013vii138. https:\/\/doi.org\/10.1093\/annonc\/mds231","journal-title":"Ann Oncol"},{"issue":"3","key":"161_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1530\/eje-13-0242","volume":"169","author":"M Terzolo","year":"2013","unstructured":"Terzolo M, Baudin AE, Ardito A, Kroiss M, Leboulleux S, Daffara F, Perotti P, Feelders RA, de Vries JH, Zaggia B, De Francia S, Volante M, Haak HR, Allolio B, Al Ghuzlan A, Fassnacht M, Berruti A (2013) Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. European journal of endocrinology 169(3):263\u2013270. https:\/\/doi.org\/10.1530\/eje-13-0242","journal-title":"European journal of endocrinology"},{"issue":"6","key":"161_CR19","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1210\/jcem.85.6.6619","volume":"85","author":"M Terzolo","year":"2000","unstructured":"Terzolo M, Pia A, Berruti A, Osella G, Ali A, Carbone V, Testa E, Dogliotti L, Angeli A (2000) Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer. J Clin Endocrinol Metab 85(6):2234\u20132238. https:\/\/doi.org\/10.1210\/jcem.85.6.6619","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"161_CR20","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMoa063360","volume":"356","author":"M Terzolo","year":"2007","unstructured":"Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker A-C, Arvat E, Ambrosi B, Loli P, Lombardi G, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L, Berruti A (2007) Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 356(23):2372\u20132380. https:\/\/doi.org\/10.1056\/NEJMoa063360","journal-title":"N Engl J Med"},{"issue":"4","key":"161_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/jamasurg.2015.4516","volume":"151","author":"Y Kim","year":"2016","unstructured":"Kim Y, Margonis GA, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem AI, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh Q-Y, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM (2016) Nomograms to predict recurrence-free and overall survival after curative resection of adrenocortical carcinoma. JAMA Surg 151(4):365\u2013373. https:\/\/doi.org\/10.1001\/jamasurg.2015.4516","journal-title":"JAMA Surg"},{"issue":"4","key":"161_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ejca.2009.12.007","volume":"46","author":"G Lughezzani","year":"2010","unstructured":"Lughezzani G, Sun M, Perrotte P, Jeldres C, Alasker A, Isbarn H, Budaus L, Shariat SF, Guazzoni G, Montorsi F, Karakiewicz PI (2010) The European network for the study of adrenal tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. European journal of cancer (Oxford, England : 1990) 46(4):713\u2013719. https:\/\/doi.org\/10.1016\/j.ejca.2009.12.007","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"issue":"6","key":"161_CR23","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.surg.2014.08.018","volume":"156","author":"EA Asare","year":"2014","unstructured":"Asare EA, Wang TS, Winchester DP, Mallin K, Kebebew E, Sturgeon C (2014) A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I\/II disease. Surgery 156(6):1378\u20131385; discussion 1385-1376. https:\/\/doi.org\/10.1016\/j.surg.2014.08.018","journal-title":"Surgery"},{"issue":"1","key":"161_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1507\/endocrj.K07-079","volume":"55","author":"R Morimoto","year":"2008","unstructured":"Morimoto R, Satoh F, Murakami O, Suzuki T, Abe T, Tanemoto M, Abe M, Uruno A, Ishidoya S, Arai Y, Takahashi K, Sasano H, Ito S (2008) Immunohistochemistry of a proliferation marker Ki67\/MIB1 in adrenocortical carcinomas: Ki67\/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocr J 55(1):49\u201355","journal-title":"Endocr J"},{"issue":"7","key":"161_CR25","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1210\/jc.2005-2730","volume":"91","author":"G Abiven","year":"2006","unstructured":"Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J (2006) Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91(7):2650\u20132655. https:\/\/doi.org\/10.1210\/jc.2005-2730","journal-title":"J Clin Endocrinol Metab"},{"issue":"50","key":"161_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3238\/arztebl.2010.0885","volume":"107","author":"S Johanssen","year":"2010","unstructured":"Johanssen S, Hahner S, Saeger W, Quinkler M, Beuschlein F, Dralle H, Haaf M, Kroiss M, Jurowich C, Langer P, Oelkers W, Spahn M, Willenberg HS, Mader U, Allolio B, Fassnacht M (2010) Deficits in the management of patients with adrenocortical carcinoma in Germany. Deutsches Arzteblatt international 107(50):885\u2013891. https:\/\/doi.org\/10.3238\/arztebl.2010.0885","journal-title":"Deutsches Arzteblatt international"},{"issue":"4","key":"161_CR27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/cen.12174","volume":"79","author":"DS Freire","year":"2013","unstructured":"Freire DS, Siqueira SA, Zerbini MC, Wajchenberg BL, Correa-Giannella ML, Lucon AM, Pereira MA (2013) Development and internal validation of an adrenal cortical carcinoma prognostic score for predicting the risk of metastasis and local recurrence. Clin Endocrinol 79(4):468\u2013475. https:\/\/doi.org\/10.1111\/cen.12174","journal-title":"Clin Endocrinol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-019-00161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s42000-019-00161-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-019-00161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T02:51:12Z","timestamp":1607482272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s42000-019-00161-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1007\/s42000-019-00161-1","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,10]]},"assertion":[{"value":"13 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o ethics committee, a member of the National Ethics Committee for Clinical Research (authorization number 113\/19). All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Authorization to perform this retrospective study without individual consent was granted by Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o ethics committee providing that patients\u2019 privacy was preserved adequately (authorization number 113\/19).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}